115 related articles for article (PubMed ID: 5158658)
1. [Immunogenic properties of an experimental vaccine against foot-and-mouth disease].
Siusiukin AA; Kravets IK; Tsvetkova NE; Pavlov VG
Veterinariia; 1971 May; 5():40-2. PubMed ID: 5158658
[No Abstract] [Full Text] [Related]
2. Development of an effective vaccine against foot-and-mouth disease with partially purified and concentrated virus antigen.
Sen AK; Saha SN
Acta Virol; 1994 Feb; 38(1):17-9. PubMed ID: 8067308
[TBL] [Abstract][Full Text] [Related]
3. [Immunogenic properties of inactivated cultured foot-and-mouth disease vaccine].
Siusiukin AA; Kravets IK; Siusiukina MS; Efimov NI; Sergeev VA; Mel'nik RI
Veterinariia; 1967 Apr; 44(4):17-8. PubMed ID: 5615318
[No Abstract] [Full Text] [Related]
4. Early response of cattle and swine to inactivated foot-and-mouth disease vaccine.
Graves JH; McKercher PD; Farris HE; Cowan KM
Res Vet Sci; 1968 Jan; 9(1):35-40. PubMed ID: 5689040
[No Abstract] [Full Text] [Related]
5. [Comparative testing of methods for the control of foot-and-mouth disease vaccines on guinea pigs].
Tekerlekov P; Mitev G; Nikolova E; Gergov P
Vet Med Nauki; 1975; 12(1):25-9. PubMed ID: 1209994
[TBL] [Abstract][Full Text] [Related]
6. Development of novel strategies to control foot-and-mouth disease: marker vaccines and antivirals.
Grubman MJ
Biologicals; 2005 Dec; 33(4):227-34. PubMed ID: 16289996
[TBL] [Abstract][Full Text] [Related]
7. [On the immunizing properties of GOAL-formol vaccine and GNKI dry virus vaccine against foot-and-mouth disease].
Lazarev PS; Amelin IP; Zaslonov MS
Veterinariia; 1966 Sep; 43(9):30-1. PubMed ID: 6011469
[No Abstract] [Full Text] [Related]
8. [The efficacy of foot and mouth disease vaccines after long- term storage].
Wittmann G
Berl Munch Tierarztl Wochenschr; 1980 Jan; 93(2):33-4. PubMed ID: 6248022
[No Abstract] [Full Text] [Related]
9. [On the production of monovalent foot-and-mouth disease vaccine concentrate from tissue culture virus type O].
Mitev G; Wassilewa L; Tekerlekov P
Arch Exp Veterinarmed; 1966 Mar; 20(1):85-90. PubMed ID: 4293436
[No Abstract] [Full Text] [Related]
10. Comparison of immune responses against foot-and-mouth disease virus induced by fusion proteins using the swine IgG heavy chain constant region or beta-galactosidase as a carrier of immunogenic epitopes.
Li G; Chen W; Yan W; Zhao K; Liu M; Zhang J; Fei L; Xu Q; Sheng Z; Lu Y; Zheng Z
Virology; 2004 Oct; 328(2):274-81. PubMed ID: 15464847
[TBL] [Abstract][Full Text] [Related]
11. [Preliminary study of the synergy of variants in the matter of foot-and-mouth disease. Action on the immunogenic quality of antiaphthous vaccines].
Fontaine J; Roumiantzeff M; Dubouclard C; Mackowiak C
Bull Acad Vet Fr; 1966 Jun; 39(6):229-37. PubMed ID: 6006997
[No Abstract] [Full Text] [Related]
12. Experiments on an early protection against foot-and-mouth disease virus.
Liebermann HT; Thalmann G; Bartels T; Nöckler A
Acta Virol; 1993; 37(2-3):181-3. PubMed ID: 8105663
[TBL] [Abstract][Full Text] [Related]
13. [Efficacy of an emergency vaccine against foot and mouth disease in pigs].
Eblé P
Tijdschr Diergeneeskd; 2007 Aug; 132(16):617-9. PubMed ID: 17849910
[No Abstract] [Full Text] [Related]
14. Comparison of immune responses to different foot-and-mouth disease genetically engineered vaccines in guinea pigs.
Yao Q; Qian P; Huang Q; Cao Y; Chen H
J Virol Methods; 2008 Jan; 147(1):143-50. PubMed ID: 17963851
[TBL] [Abstract][Full Text] [Related]
15. [Apropos of the conclusions (Point I, Section E) of the 11th conference of the Permanent Commission on Foot-and-Mouth Disease of the International Office of Epizootic Diseases in Paris].
Röhrer H
Bull Off Int Epizoot; 1966; 65(11):1921-8. PubMed ID: 5994040
[No Abstract] [Full Text] [Related]
16. Protective immune response against foot-and-mouth disease virus challenge in guinea pigs vaccinated with recombinant P1 polyprotein expressed in Pichia pastoris.
Balamurugan V; Renji R; Venkatesh G; Reddy GR; Nair SP; Ganesh K; Suryanarayana VV
Arch Virol; 2005 May; 150(5):967-79. PubMed ID: 15662485
[TBL] [Abstract][Full Text] [Related]
17. [Specific immunoprophylaxis trials with calves against foot-and-mouth disease].
Tekerlekov P; Uruchev K; Nikolova E; Genov I; Tsutsumanski V
Vet Med Nauki; 1980; 17(2):28-35. PubMed ID: 6254238
[TBL] [Abstract][Full Text] [Related]
18. Chimeric foot-and-mouth disease viruses: evaluation of their efficacy as potential marker vaccines in cattle.
Fowler VL; Paton DJ; Rieder E; Barnett PV
Vaccine; 2008 Apr; 26(16):1982-9. PubMed ID: 18342409
[TBL] [Abstract][Full Text] [Related]
19. High potency vaccines induce protection against heterologous challenge with foot-and-mouth disease virus.
Brehm KE; Kumar N; Thulke HH; Haas B
Vaccine; 2008 Mar; 26(13):1681-7. PubMed ID: 18313814
[TBL] [Abstract][Full Text] [Related]
20. The influence of aluminium hydroxide content, dose volume and the inclusion of saponin on the efficacy of inactivated foot-and-mouth disease vaccines.
Hyslop NS; Morrow AW
Res Vet Sci; 1969 Mar; 10(2):109-20. PubMed ID: 5818030
[No Abstract] [Full Text] [Related]
[Next] [New Search]
